Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


Pharmacogenomics Market in LAMEA is expected to register a CAGR of 9.9% during the forecast period (2019-2025) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report LAMEA Pharmacogenomics Market, published by KBV research, the LAMEA Pharmacogenomics Market would witness market growth of 9.9% CAGR during the forecast period (2019-2025).

The Brazil market dominated the LAMEA Electrophoresis Market by Country in 2018, growing at a CAGR of 9.6 % during the forecast period. The Argentina market is expected to witness a CAGR of 11.2% during (2019 - 2025). Additionally, The UAE market is expected to witness a CAGR of 9.9% during (2019 - 2025).

The Oncology market dominated the LAMEA Pharmacogenomics Market by Application in 2018, growing at a CAGR of 9.2 % during the forecast period. The Psychiatry market is expected to witness a CAGR of 10.4% during (2019 - 2025).

The Hospitals and Clinics market dominated the Argentina Pharmacogenomics Market by End User in 2018, thereby, achieving a market value of $57.2 million by 2025, growing at a CAGR of 10.2 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 10.9% during (2019 - 2025).

Full Report: https://www.kbvresearch.com/lamea-pharmacogenomics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.

LAMEA Pharmacogenomics Market Segmentation

By Technology

  • Sequencing
  • Polymerase Chain Reaction
  • Electrophoresis
  • Mass Spectrometry
  • Microarray
  • Others

By Application

  • Oncology
  • Psychiatry
  • Infectious Diseases
  • Neurological Diseases
  • Pain management
  • Cardiovascular Diseases
  • Others

By End User

  • Hospitals and Clinics
  • Research Institutions
  • Academic Institutes

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Empire Genomics LLC
  • Illumina, Inc.
  • OneOme LLC
  • Myriad Genetics Inc.
  • Thermo Fisher Scientific, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Bayer AG
  • Opko Health, Inc.
  • Becton, Dickinson and Company

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Pharmacogenomics Market Related Reports:

Global Market

North America Market

Europe Market

Asia Pacific Market



SUBSCRIPTION MODEL